Substrate Imaging to Guide Primary Prevention Implantable Cardioverter-Defibrillator in Ischemic Cardiomyopathy Fanciful or Realistic Aim? COMMENT

被引：1
|
作者：
Gupta, Ankur [1 ]
机构：
[1] Henry Ford Hosp, Dept Internal Med, Div Cardiol, Detroit, MI 48202 USA
来源：
JACC-CARDIOVASCULAR IMAGING | 2020年 / 13卷 / 08期
关键词：
cardiac magnetic resonance; implantable cardioverter-defibrillator; positron-emission tomography; ventricular arrhythmia; SUDDEN CARDIAC DEATH; VENTRICULAR-ARRHYTHMIAS; RISK; PREDICTS; SHOCKS; HEART; SCAR; CMR;
D O I：
10.1016/j.jcmg.2020.05.013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1767 / 1770
页数：4
相关论文
共 50 条
  • [1] Implantable Cardioverter-defibrillator Therapy for Hypertrophic Cardiomyopathy: Usefulness in Primary and Secondary Prevention
    Sarrias, Axel
    Galve, Enrique
    Sabate, Xavier
    Moya, Angel
    Anguera, Ignacio
    Nunez, Elaine
    Villuendas, Roger
    Alcalde, Oscar
    Garcia-Dorado, David
    REVISTA ESPANOLA DE CARDIOLOGIA, 2015, 68 (06): : 492 - 496
  • [2] Predictors of Implantable Cardioverter-Defibrillator Use in Patients with Ischemic Cardiomyopathy
    Kelly, Ryan
    Buth, Karen J.
    Heimrath, Olivier
    Basta, Magdy
    Legare, Jean-Francois
    OPEN CARDIOVASCULAR MEDICINE JOURNAL, 2010, 4 : 206 - 213
  • [3] Low Agreement Among Guidelines for Primary Prevention Implantable Cardioverter-Defibrillator Recommendations in Hypertrophic Cardiomyopathy
    Scolari, Fernando Luis
    Garbin, Henrique Iahnke
    de Carvalho, Guilherme Dagostin
    Rodrigues, Fernanda Thomaz
    de Menezes, Rodrigo Araujo
    Correia, Edileide de Barros
    Bittencourt, Marcelo Imbroinise
    AMERICAN JOURNAL OF CARDIOLOGY, 2025, 236 : 86 - 91
  • [4] An implantable cardioverter-defibrillator for primary prevention in non-ischemic cardiomyopathy: A systematic review and meta-analysis
    Wasiak, Michal
    Tajstra, Mateusz
    Kosior, Dariusz
    Gasior, Mariusz
    CARDIOLOGY JOURNAL, 2021,
  • [5] An implantable cardioverter-defibrillator for primary prevention in non-ischemic cardiomyopathy: A systematic review and meta-analysis
    Wasiak, Michal
    Tajstra, Mateusz
    Kosior, Dariusz
    Gasior, Mariusz
    CARDIOLOGY JOURNAL, 2023, 30 (01) : 117 - 124
  • [6] Indications for implantable cardioverter-defibrillator placement in ischemic cardiomyopathy and after myocardial infarction
    Mountantonakis S.E.
    Hutchinson M.D.
    Current Heart Failure Reports, 2011, 8 (4) : 252 - 259
  • [7] Myocardial Scar Characterization and Future Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter-Defibrillator
    Noordman, Alwin B. P.
    Maass, Alexander H.
    Groenveld, Hessel
    Mulder, Bart A.
    Rienstra, Michiel
    Blaauw, Yuri
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [8] Implantable cardioverter-defibrillator implantation for primary and secondary prevention: indications and outcomes
    Pick, Justin M.
    Batra, Anjan S.
    CARDIOLOGY IN THE YOUNG, 2017, 27 : S126 - S131
  • [9] Programming implantable cardioverter-defibrillator in primary prevention: Guideline concordance and outcomes
    Ananwattanasuk, Teetouch
    Tanawuttiwat, Tanyanan
    Chokesuwattanaskul, Ronpichai
    Lathkar-Pradhan, Sangeeta
    Barham, Waseem
    Oral, Hakan
    Thakur, Ranjan K.
    Jongnarangsin, Krit
    HEART RHYTHM, 2020, 17 (07) : 1101 - 1106
  • [10] Implantable Cardioverter-Defibrillator therapy for primary prevention of sudden cardiac death in patients with severe Chagas cardiomyopathy
    Cardinalli-Neto, Augusto
    Nakazone, Marcelo A.
    Grassi, Luciano V.
    Tavares, Bruno G.
    Bestetti, Reinaldo B.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 150 (01) : 94 - 95
12345